| The global impact of the coronavirus pandemic J Hiscott, M Alexandridi, M Muscolini, E Tassone, E Palermo, M Soultsioti, ... Cytokine & growth factor reviews 53, 1-9, 2020 | 409 | 2020 |
| The Coronavirus pandemic–2022: Viruses, variants & vaccines M Alexandridi, J Mazej, E Palermo, J Hiscott Cytokine & growth factor reviews 63, 1-9, 2022 | 51 | 2022 |
| Dengue virus immunopathogenesis: Lessons applicable to the emergence of Zika virus D Olagnier, D Amatore, L Castiello, M Ferrari, E Palermo, MS Diamond, ... Journal of Molecular Biology 428 (17), 3429-3448, 2016 | 50 | 2016 |
| Dengue virus targets Nrf2 for NS2B3-mediated degradation leading to enhanced oxidative stress and viral replication M Ferrari, A Zevini, E Palermo, M Muscolini, M Alexandridi, MP Etna, ... Journal of virology 94 (24), 10.1128/jvi. 01551-20, 2020 | 45 | 2020 |
| Type I interferons in COVID-19 pathogenesis E Palermo, D Di Carlo, M Sgarbanti, J Hiscott Biology 10 (9), 829, 2021 | 38 | 2021 |
| Activation of latent HIV-1 T cell reservoirs with a combination of innate immune and epigenetic regulators E Palermo, C Acchioni, D Di Carlo, A Zevini, M Muscolini, M Ferrari, ... Journal of virology 93 (21), 10.1128/jvi. 01194-19, 2019 | 30 | 2019 |
| An optimized retinoic acid-inducible gene I agonist M8 induces immunogenic cell death markers in human cancer cells and dendritic cell activation L Castiello, A Zevini, E Vulpis, M Muscolini, M Ferrari, E Palermo, ... Cancer Immunology, Immunotherapy 68, 1479-1492, 2019 | 24 | 2019 |
| SIRT1 modulates the sensitivity of prostate cancer cells to vesicular stomatitis virus oncolysis M Muscolini, L Castiello, E Palermo, A Zevini, M Ferrari, D Olagnier, ... Journal of Virology 93 (15), 10.1128/jvi. 00626-19, 2019 | 24 | 2019 |
| Antiviral potential of the antimicrobial drug atovaquone against SARS-CoV-2 and emerging variants of concern ME Carter-Timofte, R Arulanandam, N Kurmasheva, K Fu, G Laroche, ... ACS infectious diseases 7 (11), 3034-3051, 2021 | 23 | 2021 |
| Alternate NF-κB-independent signaling reactivation of latent HIV-1 provirus C Acchioni, AL Remoli, G Marsili, M Acchioni, I Nardolillo, R Orsatti, ... Journal of Virology 93 (18), 10.1128/jvi. 00495-19, 2019 | 22 | 2019 |
| Fighting HIV-1 persistence: at the crossroads of “shoc-K and B-lock” C Acchioni, E Palermo, S Sandini, M Acchioni, J Hiscott, M Sgarbanti Pathogens 10 (11), 1517, 2021 | 18 | 2021 |
| Inhibition of glycolysis impairs retinoic acid-inducible gene I–mediated antiviral responses in primary human dendritic cells A Zevini, E Palermo, D Di Carlo, M Alexandridi, S Rinaldo, A Paone, ... Frontiers in cellular and infection microbiology 12, 910864, 2022 | 6 | 2022 |
| Dolutegravir-Based Regimen for Maintenance of Viral Suppression in People Living with HIV: 48-Week Results in Real-Life Setting D Di Carlo, F Falasca, E Palermo, I Mezzaroma, C Fimiani, G Siccardi, ... AIDS Research and Human Retroviruses 37 (6), 478-485, 2021 | 5 | 2021 |
| Virus-like particle–mediated delivery of the RIG-I agonist M8 induces a type I interferon response and protects cells against viral infection E Palermo, M Alexandridi, D Di Carlo, M Muscolini, J Hiscott Frontiers in Cellular and Infection Microbiology 12, 1079926, 2022 | 2 | 2022 |
| Fighting HIV-1 Persistence: At the Crossroads of Shoc-K and B-Lock”. Pathogens 2021, 10, 1517 C Acchioni, E Palermo, S Sandini, M Acchioni, J Hiscott, M Sgarbanti s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | 1 | 2021 |
| Inactivation of the Niemann Pick C1 cholesterol transporter 1 (NPC1) restricts SARS-CoV-2 infection (preprint) P La Rosa, J Tiberi, E Palermo, S Tiano, M Cortese, J Hiscott, ... | | 2023 |
| Inactivation of the Niemann Pick C1 cholesterol transporter 1 (NPC1) restricts SARS-CoV-2 infection P La Rosa, J Tiberi, E Palermo, S Tiano, M Cortese, J Hiscott, ... bioRxiv, 2023.12. 13.571570, 2023 | | 2023 |
